Katherine Galluzzi, DO
Geriatric Medicine · Philadelphia, PANPI 1336140979
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,075 of the $6,854 with a category attached, or 74.0%. Lilly USA, LLC accounts for 97.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $6,612 and has fallen 96.7% since, to $219 in 2025. Among geriatric medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $253.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$7K
- Otsuka America Pharmaceutical, Inc.$54
- Eisai Inc.$48
- Scilex Pharmaceuticals Inc.$36
- Collegium Pharmaceutical, Inc.$21
- Neurocrine Biosciences, Inc.$20
- plus $18 from 1 others
What the payments were for
- Consulting fees$5,07574%
- Travel & lodging$1,23818%
- Food & beverage$5418%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 17 | $6,656 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Eisai Inc. | 2 | $48 |
| Scilex Pharmaceuticals Inc. | 2 | $36 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Bayer | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KISUNLA$5,972
How this compares
$6,854 in reported general payments places this provider in the 90th percentile of 217 geriatric medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 12 | $5,369 |
| Insulin Lispro Protamine MixInsulin Lispro Protamin/Lispro | 33 | $1,344 |
| Exemestane | 13 | $1,251 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $924 |
| Atorvastatin Calcium | 94 | $906 |
| Donepezil Hcl | 13 | $727 |
| Potassium Chloride | 11 | $490 |
| Hydralazine Hcl | 13 | $490 |
| Rosuvastatin Calcium | 19 | $461 |
| Lisinopril | 40 | $344 |
| Gabapentin | 20 | $321 |
| Pantoprazole Sodium | 28 | $297 |
| Latanoprost | 17 | $276 |
| Mirtazapine | 16 | $264 |
| Bupropion Hcl | 13 | $255 |
Paid to pharmacies, not to this prescriber.
Other geriatric medicine in Philadelphia
- Richard StefanacciPhiladelphia$146K
- Michele ZaworaPhiladelphia$21K
- Jason KarlawishPhiladelphia$11K
- Ellen ZagrebelskyPhiladelphia$7K
- Vladimir ZagrebelskyPhiladelphia$6K
- Lesley CarsonPhiladelphia$3K
- Helen VolokhonskyPhiladelphia$3K
- Jerry JohnsonPhiladelphia$2K
- Nicol JosephPhiladelphia$528
- James LinErie$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.